5-Bromo-4-chloro-3-indolyl acetate, 95.0%, 250mg

TERT-BUTYL 4-(BROMOMETHYL)-4-FLUOROPIPERIDINE-1-CARBOXYLATE, 95.0%, 10g

3-Fluoro-4-methylacetophenone, 97.0%, 10g

1-BOC-4-ETHYNYL-4-HYDROXYPIPERIDINE, 95.0%, 25g

Tris(4-nitrophenyl)amine, 95.0%, 10g

Rubidium ICP standard solution, ROTI®Star, 1000 mg/l Rb, density (D) ~1 g/cm³

1-(2,3-Dihydroxy-4-methoxyphenyl)ethanone, 95.0%, 250mg

2-Bromo-1-(1-methyl-1H-imidazol-2-yl)ethanone, 95.0%, 100mg

Methyl trans-3-Pentenoate>90.0%(GC)5mL

(2R,4R)-4-(tert-Butoxy)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid, 98%, 1g

1-(4-morpholinyl)acetone, 95.0%, 5g

N-((1S,2S)-2-Amino-1,2-diphenylethyl)methanesulfonamide, 97%, 250mg

(2S,3S,4S,5R,6S)-6-{[4,6-dihydroxy-2-(4-hydroxyphenyl)-5-oxo-5H-chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid, 95%, 5g